Show simple item record

dc.contributor.authorSerazin, Nathan A
dc.contributor.authorEdem, Bassey
dc.contributor.authorWilliams, Sarah R
dc.contributor.authorOrtiz, Justin R
dc.contributor.authorKawade, Anand
dc.contributor.authorDas, Manoj Kumar
dc.contributor.authorŠubelj, Maja
dc.contributor.authorEdwards, Kathryn M
dc.contributor.authorParida, Shreemanta K
dc.contributor.authorWartel, T Anh
dc.contributor.authorMunoz, Flor M
dc.contributor.authorBastero, Patricia
dc.date.accessioned2021-03-04T17:34:32Z
dc.date.available2021-03-04T17:34:32Z
dc.date.issued2021-01-28
dc.identifier.urihttp://hdl.handle.net/10713/14811
dc.description.abstractThis is a Brighton Collaboration Case Definition of the term “Acute Respiratory Distress Syndrome – ARDS” to be utilized in the evaluation of adverse events following immunization. The Case Definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2 vaccines and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected Expert Reviewers prior to submission. The comments of the reviewers were taken into consideration and edits incorporated in this final manuscript. © 2021 The Authorsen_US
dc.description.urihttps://doi.org/10.1016/j.vaccine.2021.01.053en_US
dc.language.isoenen_US
dc.publisherElsevier Ltd.en_US
dc.relation.ispartofVaccineen_US
dc.rightsCopyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.en_US
dc.subjectARDSen_US
dc.subjectAcute respiratory distress syndromeen_US
dc.subjectAdulten_US
dc.subjectAdverse eventen_US
dc.subjectCOVID-19en_US
dc.subjectCase definitionen_US
dc.subjectGuidelinesen_US
dc.subjectImmunizationen_US
dc.subjectPediatricen_US
dc.titleAcute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.vaccine.2021.01.053
dc.identifier.pmid33583673
dc.source.countryNetherlands


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record